Related references
Note: Only part of the references are listed.Factors affecting the long-term response to tacrolimus in renal transplant patients: Pharmacokinetic and pharmacogenetic approach
Paraskevi F. Katsakiori et al.
International Journal of Medical Sciences (2012)
Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety
Qian Xiang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2009)
The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity
C. Bellarosa et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Stepwise Regression Analysis of the Determinants of Blood Tacrolimus Concentrations in Chinese Patients with Liver Transplant
Z. Jin et al.
MEDICINAL CHEMISTRY (2009)
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2009)
Genetic Polymorphisms in CYP3A5 and MDR1 Genes and Their Correlations With Plasma Levels of Tacrolimus and Cyclosporine in Renal Transplant Recipients
J. Mendes et al.
TRANSPLANTATION PROCEEDINGS (2009)
A limited sampling strategy for tacrolimus in renal transplant patients
Binu S. Mathew et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects
Yoshiharu Suzuki et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects
Ji H. Choi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates:: Guidelines from an experimental study
V. Haufroid et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P4502C9
Lai-San Tham et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients
Satohiro Masuda et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements
Salim Fredericks et al.
TRANSPLANTATION (2006)
Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
Jean Nicholas Roy et al.
PHARMACOGENETICS AND GENOMICS (2006)
Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5*3/*3 nonexpressors
J Wang et al.
TRANSPLANT IMMUNOLOGY (2006)
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements:: proposal for a new dosing regimen
EA Sconce et al.
BLOOD (2005)
The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?
DA Hesselink et al.
PHARMACOGENOMICS (2005)
Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacolunetics in de novo renal allograft recipients
DRJ Kuypers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Genetic variability in CYP3A5 and its possible consequences
HG Xie et al.
PHARMACOGENOMICS (2004)
MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients
I Mai et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
N Tsuchiya et al.
TRANSPLANTATION (2004)
Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients
E Thervet et al.
TRANSPLANTATION (2003)
P-glycoprotein: from genomics to mechanism
SV Ambudkar et al.
ONCOGENE (2003)
Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor
JM Rosenfeld et al.
MOLECULAR ENDOCRINOLOGY (2003)
Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients
D Anglicheau et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)